Biomed AG is a Biotech company based in Dübendorf (Zurich) recorded by Swissmedic as the authorisation holder for 31 human medicines. That places it 53 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Biotech |
|---|---|
| City | Dübendorf |
| Canton | Zurich |
| Authorisation holder | Yes |
| Medicines | 31 |
| Founded | 1951 |
| Employees | 51-200 |
| Parent group | Not available |
| Activity | Not available |
| Website | biomed.ch |
Medicines authorised in Switzerland
Biomed AG is recorded by Swissmedic as the authorisation holder for 31 human medicines. The table shows 31 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
31 of 31 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| 1001 Blattgrün Dragées | 26293 | E | A16AX | 1962-10-11 |
| Allsan Mariendistel | 54110 | D | A05BA03 | 1998-06-26 |
| B12 Ankermann 1000 μg | 68796 | D | B03BA01 | 2024-01-15 |
| Biotin-Biomed forte 5 mg | 34149 | D | A11HA05 | 1968-11-22 |
| Bronchipret Thymian Efeu | 65999 | D | R05CA10 | 2017-05-30 |
| Bronchipret TP | 57543 | D | R05CA10 | 2008-06-17 |
| Canephron | 67419 | D | G04BX | 2020-10-01 |
| Emge Biomed | 68556 | D | A12CC04 | 2023-01-27 |
| Magnesiocard | 45728 | B | A12CC05 | 1984-05-28 |
| Magnesiocard | 50065 | B | A12CC05 | 1989-11-28 |
| Magnesiocard 10 Grapefruit | 53210 | B | A12CC05 | 1995-11-14 |
| Magnesiocard 2.5 | 45730 | B | A12CC05 | 1984-05-28 |
| Magnesiocard 5 Orange | 45726 | B | A12CC05 | 1984-05-28 |
| Magnesiocard 7.5 | 51458 | B | A12CC05 | 1993-04-08 |
| Magnesium Biomed | 47413 | D | A12CC05 | 1986-09-24 |
| Magnesium Biomed | 50143 | D | A12CC30 | 1991-06-28 |
| Magnesium Biomed | 53889 | D | A12CC05 | 1998-06-11 |
| milgamma 300 mg | 68695 | D | - | 2023-04-06 |
| Parapic | 42778 | D | D04AX | 1980-06-11 |
| Sensicutan | 66821 | D | D04AX | 2019-03-06 |
| Sinupret | 53159 | D | R05X | 1998-05-06 |
| Sinupret extract | 65251 | D | R05X | 2016-02-09 |
| Sinupret Sirup | 58752 | D | R05X | 2010-07-12 |
| Sinupret Tropfen | 53160 | D | R05X | 1998-05-06 |
| SteriSwab Biomed | 66691 | D | - | 2019-03-15 |
| Thiogamma 600 mg/ 50 ml | 68983 | B | - | 2023-05-12 |
| Thiogamma 600 oral | 68288 | B | - | 2022-05-02 |
| Traumaplant | 53712 | D | M02AX10 | 1998-07-14 |
| Trederol 20000 I.E. | 69041 | B | A11CC05 | 2023-12-19 |
| Vitafediol 0.266 mg | 69012 | B | A11CC06 | 2024-07-17 |
| Zink Biomed 20 | 55476 | B/D | A12CB02 | 2003-06-06 |
Frequently asked questions
How many medicines does Biomed AG have authorised in Switzerland?
Biomed AG is recorded by Swissmedic as the authorisation holder for 31 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Biomed AG based?
The Swiss location recorded for Biomed AG is Dübendorf, Zurich.
Is Biomed AG a Swissmedic authorisation holder?
Yes. Biomed AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.